Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tsukushi A·M Compound Powder is a combination gastrointestinal medication developed and marketed by FUJIFILM Toyama Chemical. It is formulated as a powder containing a blend of digestive enzymes (diastase and pancreatin), antacids (sodium bicarbonate and magnesium carbonate), and various stomachic herbal powders (gentian, swertia, cinnamon, ginger, clove, and fennel). The drug is indicated for the treatment of gastrointestinal symptoms such as gastritis, dyspepsia, heartburn, stomach heaviness, and loss of appetite. It works by neutralizing stomach acid, facilitating the digestion of carbohydrates and proteins, and stimulating gastric secretion and motility through its herbal components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tsukushi A·M Compound Powder.